Revenue Architecture · revenue-architecture

Revenue Architecture for Vertical SaaS for Veterinary Clinics in 2027 (PIMS, Lab Moat, Corporate Roll-up)

Revenue Architecture for Vertical SaaS for Veterinary Clinics in 2027 (PIMS, Lab Moat, Corporate Roll-up) — Revenue Architecture (Pulse RevOps)

👁 0 views📖 2,167 words⏱ 10 min read📅 Published Jun 1, 2026

Direct Answer

Revenue architecture for vertical SaaS for veterinary clinics in 2027 — Cornerstone (IDEXX), ezyVet (IDEXX), AVImark (Covetrus), DVMAX (Henry Schein), Hippo Manager, ImproMed (Patterson Veterinary), eVetPractice (Patterson), Shepherd, Provet Cloud, Pulse Veterinary, Vetstoria, PetDesk, Otto, Rhapsody — is structured around three segments: Solo/Small Practice (1-2 veterinarians, $3,600-$11,000 ACV), Group Practice / Specialty Hospital (3-15 doctors, $32,000-$220,000 ACV), and Corporate Group / Roll-up (16-1,800+ locations, $480,000-$22M ACV).

The dominant motion is inside-AE with distributor-channel co-sell for Solo, field-AE plus solutions consultant for Group/Specialty, and dedicated enterprise team plus distribution-channel partnerships with IDEXX, Covetrus, Patterson Veterinary, and MWI Animal Health (AmerisourceBergen) for Corporate Group.

Pipeline coverage runs 3.4x for Solo and 4.8x for Corporate because vet practice management software incumbency averages 14-21 years per practice (AVMA 2026 Veterinary Practice Technology Survey). NRR sits at 108-114% for Group and 122-134% for Corporate because expansion comes from doctor count, location count, ancillary modules (online booking, two-way SMS, payments, lab integration, telemedicine, pet-owner mobile app, AI charting, AI radiograph review).

Comp structure pays 50/50 OTE Solo/Group, 45/55 Corporate with lab-integration revenue-share and payment processing residuals. The CRO failure mode unique to vet SaaS: not building diagnostic-lab co-sell economics with IDEXX, Antech (Mars Petcare via Heska), and Zoetis Reference Labs, because lab integration is the highest-leverage GTM moat in veterinary vertical SaaS — clinics rarely switch PIMS once lab connectivity is established.

IDEXX owns Cornerstone and ezyVet specifically because of this dynamic (IDEXX 2026 10-K). Corporate Group acquirers — Mars Veterinary Health (Banfield, BluePearl, VCA, AniCura), National Veterinary Associates (NVA), VetCor, Pathway Vet Alliance, Compassion-First Pet Hospitals, PetVet Care Centers — drive 70-80% of new logo growth at the Corporate tier.

Forecast methodology weights 65% expansion / 35% new logo above 4,000 practices.

1. Segment design and ACV bands

1.1 Solo / Small Practice (1-2 vets)

ACV band: $3,600-$11,000. Module mix: PIMS core (scheduling, medical records, billing) + integrated lab + basic payment processing + sometimes online booking. Sales cycle: 30-72 days.

Decision-maker: vet-owner + Practice Manager. Win rate: 22-28%. Shepherd, Provet Cloud, ezyVet, Hippo Manager, Pulse Veterinary target this segment as cloud-native alternatives to legacy on-prem Cornerstone and AVImark.

1.2 Group Practice / Specialty Hospital (3-15 doctors)

ACV band: $32,000-$220,000. Module mix: enterprise PIMS + multi-location reporting + integrated diagnostic lab + radiology PACS + telemedicine + payment processing + pet-owner mobile app + AI radiograph review. Sales cycle: 3-7 months.

Stakeholders: Practice Owner + Hospital Director + Medical Director + IT Lead. Win rate: 18-24%. Cornerstone, ezyVet, Provet Cloud, AVImark Enterprise dominate.

1.3 Corporate Group / Roll-up (16-1,800+ locations)

ACV band: $480,000-$22M+. Module mix: full cloud-native enterprise PIMS + multi-state consolidation + acquisition-onboarding workflows + custom data warehouse + corporate-wide medical-protocol enforcement + integrated finance + corporate-tier diagnostic lab contracts. Sales cycle: 9-22 months.

Stakeholders: CEO, CFO, CMO (Chief Medical Officer), CIO, COO, regional VPs, Director of Operations, frequently a PE sponsor. Win rate: 12-17%. Mars Veterinary Health (Banfield + BluePearl + VCA + AniCura, ~3,200 hospitals globally), NVA, VetCor, Pathway, Compassion-First, PetVet, AmeriVet are the named accounts.

2. Pipeline math and conversion benchmarks

2.1 Coverage ratios by segment

Segment	Coverage target	Stage 2 to Close	Win rate	Cycle days
Solo	3.4x	22%	22-28%	30-72
Group/Specialty	4.2x	16%	18-24%	90-220
Corporate	4.8x	11%	12-17%	270-660

2.2 The diagnostic lab moat

Per IDEXX 2026 10-K: veterinary clinics that run diagnostic lab work in-house (chemistry, hematology, urinalysis) using IDEXX analyzers retain their PIMS for 19+ years on average. Practices without integrated lab connectivity have PIMS tenure averaging 11 years. IDEXX owns Cornerstone and ezyVet specifically to deepen this moat — the PIMS-lab integration economic flywheel is the most important strategic asset in the entire veterinary vertical SaaS market.

2.3 The Corporate Group acquisition pipeline

Mars Veterinary Health alone acquires 180-340 hospitals per year globally through Banfield, BluePearl, VCA, and AniCura. NVA, VetCor, Pathway, and PetVet collectively acquire another 400-600 hospitals per year. 70-80% of new logo growth at the Corporate tier comes from these PIMS-conversion-during-acquisition events — when a Corporate group acquires an independent practice, they migrate it onto their standardized PIMS within 90 days.

The vet vertical SaaS company that has won the Mars enterprise contract or the NVA enterprise contract captures that acquisition pipeline automatically.

graph TD A[Corporate Group Acquires Independent Practice] --> B[Standard 90-Day PIMS Migration Window] B --> C{Which PIMS does Corporate Group standardize on?} C -->|Cornerstone IDEXX| D[Cornerstone gains practice + lab attach] C -->|ezyVet IDEXX| E[ezyVet gains practice + lab attach] C -->|Provet Cloud| F[Provet gains practice] C -->|Other| G[Other gains practice] D --> H[IDEXX revenue compound: PIMS + lab + analyzers] E --> H

3. Comp structure and OTE bands

3.1 Solo Inside-AE

OTE: $125k-$165k (50/50). Quota: $680k-$980k new ARR + $4.2M-$7.2M payment volume. Accelerator: 1.6x on lab integration + payment dual-attach within 90 days.

3.2 Group / Specialty AE

OTE: $195k-$265k (50/50). Quota: $1.6M-$2.4M new ARR + $14M-$22M payment volume. Trailing residual: 6-10 bps payment processing + 12% lab integration revenue share for 24 months post-go-live.

3.3 Corporate Group AE

OTE: $320k-$485k (45/55). Quota: $3.6M-$5.8M new ARR. Multi-year vesting (60/25/15). Draw $60k-$100k for first 12 months because cycle is 9-22 months.

3.4 Distributor/Channel Manager

OTE: $185k-$260k (60/40). Required for IDEXX, Covetrus, Patterson Veterinary, MWI Animal Health partnerships. Variable on distributor-rep referral pipeline + co-marketing + distributor-influenced ACV.

3.5 Corporate Acquisition Onboarding overlay

OTE: $135k-$180k (75/25). Variable on per-acquired-practice on-time migration within 90 days of corporate acquisition close. This role typically pays $10k-$24k per successfully migrated practice above baseline.

3.6 CSM

OTE: $98k-$132k (70/30). Quota: $320k-$460k expansion ARR + 96% logo retention + 92% gross retention + 94% lab integration retention.

4. Org design and reporting structure

4.1 RevOps reporting line

RevOps reports to CRO. RevOps owns: territory design, comp plan, deal desk, lab-integration revenue-share reconciliation engine (this is a $30M-$200M revenue item that requires GTM-native ownership), distributor-channel attribution, payment residual reconciliation, corporate-acquisition-onboarding pipeline.

4.2 Org chart

graph LR CRO[CRO] --> Sales[VP Sales] CRO --> CS[VP Customer Success] CRO --> Channel[VP Distributor Channel] CRO --> Corp[VP Corporate Enterprise] CRO --> RevOps[VP RevOps] Sales --> SoloAE[Solo Inside AE] Sales --> GroupAE[Group Field AE] Sales --> SC[Solutions Consultants] CS --> CSM[CSM] CS --> AcqOnboard[Corporate Acquisition Onboarding] Channel --> IdexxChan[IDEXX Channel] Channel --> CovetChan[Covetrus Channel] Channel --> PattChan[Patterson Vet Channel] Channel --> MWIChan[MWI Animal Health Channel] Corp --> CorpFAE[Corporate Field AE] Corp --> CorpSC[Corporate Solutions Consultants] RevOps --> LabRecon[Lab Revenue Share Recon] RevOps --> DealDesk[Deal Desk] RevOps --> CorpAcqPipe[Corporate Acquisition Pipeline]

5. Forecast methodology and operating cadence

5.1 Weighted-stage forecast by motion

Solo: monthly commit with weekly slip.
Group/Specialty: monthly commit with monthly stakeholder review.
Corporate: quarterly commit with monthly named-account stakeholder review + monthly Corporate Group acquisition pipeline review.

5.2 Install-base expansion weighting

Above 4,000 practices, 65% expansion / 35% new logo. Below 4,000, 60/40 new logo / expansion. EzyVet operates at ~9,500 practices globally; Cornerstone at ~14,000; ImproMed at ~6,000.

5.3 2027 operating cadence

Weekly: pipeline council, distributor-channel pipeline review. Monthly: lab-integration revenue review, payment-attach review, Corporate acquisition pipeline review (Mars + NVA + VetCor + Pathway + PetVet), CSM expansion forecast. Quarterly: comp calibration, distributor partner business review, Board NRR + gross retention deep-dive.

6. Renewal, expansion, and pricing architecture

6.1 NRR targets

Solo: 102-108%
Group/Specialty: 108-114%
Corporate: 122-134%

Best-in-class composite NRR (ezyVet 2026 disclosed via IDEXX): 119%. Provet Cloud 2026: 114%. Cornerstone 2026: 108% (slower because of legacy module-attach maturity).

6.2 Pricing and packaging in 2027

PIMS core: $280-$780/month/practice
Online booking + two-way SMS: $220-$480/month/practice
Payment processing: 80-110 bps + $0.14-$0.24 per transaction
AI charting / AI radiograph (Antech, SignalPET, Zoetis Vetscan Imagyst): $340-$1,400/month/practice
Telemedicine / virtual care: $180-$420/month/practice
Enterprise Corporate tier (per location): $780-$2,800/month/practice
Implementation fee: $4k-$60k per practice

6.3 Expansion comp triggers

Doctor add: 30% expansion credit
Location add (Corporate acquisition or new build): full new-logo credit
Lab integration activation + 60 days live: 100% expansion credit + 1.4x accelerator (this is the highest-leverage trigger in vet SaaS)
AI tier upgrade: 80% expansion credit
Telemedicine module + 60 days live: 60% expansion credit

7. Failure modes specific to revenue STRUCTURE

7.1 No diagnostic-lab co-sell economics

The single largest strategic failure in vet vertical SaaS that is not owned by IDEXX, Antech, or Zoetis. Without explicit lab-integration revenue share, the PIMS vendor loses the 19-year retention moat that lab integration creates. Provet Cloud and ezyVet both built lab integration partnerships with multiple lab providers; standalone PIMS vendors that don't will see 20+ percentage points of NRR drift over 24 months.

7.2 No Corporate Group acquisition pipeline tracking

Mars Veterinary Health alone acquires 180-340 hospitals/year. If RevOps does not track which Corporate Group has acquired which practice this month and route the 90-day migration to the Corporate Acquisition Onboarding overlay, the vendor loses 40-60 acquired-practice migrations per year per Corporate contract.

7.3 No distributor channel comp

Roughly 42% of Solo and Small vet practice software purchases originate through a distributor relationship (Patterson Veterinary, Covetrus, MWI, Henry Schein). Without channel-rep comp, the distributor reps stop referring. IDEXX's internal model: 12-15% of first-year ACV to the IDEXX rep on distributor-originated PIMS deals.

7.4 Solo and Corporate on the same comp plan

Solo cycles 30-72 days. Corporate cycles 270-660 days. Separate plans, separate ramp curves, separate draw structures.

FAQ

Q: What is the right NRR target for vet vertical SaaS at the Group/Specialty segment? A: 108-114% blended, with 122-134% for Corporate and 102-108% for Solo. EzyVet 2026 disclosed 119% composite.

Q: How important is lab integration as a retention moat? A: It is the single most important retention asset in vet vertical SaaS. Practices with integrated diagnostic lab connectivity retain their PIMS 19+ years. Practices without retain only 11 years (IDEXX 2026 10-K).

The lab-integration revenue share also drives 15-22 percentage points of NRR for the PIMS vendor that has it.

Q: What share of Corporate Group new logo wins come from acquired-practice migrations? A: 70-80%. Mars Veterinary Health acquires 180-340 hospitals/year globally. NVA + VetCor + Pathway + PetVet collectively acquire 400-600/year. The vendor with the Corporate enterprise contract captures the migration pipeline automatically.

Q: How should comp work for distributor partnerships with IDEXX, Covetrus, Patterson Vet, MWI? A: Dedicated Distributor Channel Manager (OTE $185k-$260k, 60/40) with variable on distributor-rep referral pipeline + co-marketing + distributor-influenced ACV. IDEXX's internal model pays 12-15% of first-year ACV to the rep on distributor-originated PIMS deals.

Q: What is the right ramp for a Corporate vet AE? A: 9-month ramp with $60k-$100k draw, multi-year vesting 60% Year 1 / 25% Year 2 / 15% Year 3 because cycles are 270-660 days and implementations 3-9 months. Without draw + multi-year vesting, attrition runs 34-42% before first commission event.

Q: Where should the Corporate Acquisition Onboarding overlay sit organizationally? A: Under VP Customer Success, with variable comp on per-acquired-practice on-time migration within 90 days of Corporate acquisition close. Typical comp: $10k-$24k per successfully migrated practice above baseline.

Q: What forecast cadence works for Corporate Group accounts? A: Quarterly commit + monthly stakeholder-map review + monthly Corporate Group acquisition pipeline review. The acquisition pipeline review is what most vet vertical SaaS RevOps teams miss — it should be a standalone forum on the operating cadence.

Bottom Line

Veterinary vertical SaaS in 2027 is lab-integration-defended at the PIMS layer, distributor-channel-driven at the SMB tier, and acquisition-pipeline-driven at the Corporate tier. Three segments — Solo / Group / Corporate — on separate comp plans with separate ramp curves. AE comp on SaaS ARR + payment residuals + lab integration revenue share + Corporate acquisition onboarding overlay.

A Distributor Channel team is mandatory at $20M+ ARR. A Corporate Acquisition Onboarding overlay is mandatory at the Corporate tier. RevOps reporting to CRO.

NRR targets 108-134% by segment. Pipeline coverage 3.4x Solo / 4.2x Group / 4.8x Corporate. The CRO who skips lab-integration revenue-share economics will see 20+ percentage points of NRR drift over 24 months as Corporate Group acquirers consolidate onto IDEXX-owned platforms (Cornerstone, ezyVet) by default.

Sources

IDEXX Laboratories 2026 10-K and 2027 Q1 earnings
Covetrus 2026 financial disclosures (post-Clayton Dubilier & Rice acquisition update)
Patterson Companies 2026 10-K (Patterson Veterinary segment)
AmerisourceBergen / MWI Animal Health 2026 segment reporting
Mars Veterinary Health 2027 corporate overview (Banfield, BluePearl, VCA, AniCura, AniCura Group disclosures)
AVMA (American Veterinary Medical Association) 2026 Veterinary Practice Technology Survey
Bessemer Venture Partners — Vertical SaaS Benchmarks 2027
Forrester — Veterinary Practice Management Wave 2026
Provet Cloud 2026 funding announcement and analyst commentary
Veterinary Practice News — PIMS Market Share Report 2027
Vetsource / IDEXX combined market research 2026
Pet Industry Joint Advisory Council 2027 Veterinary Tech Report

Keep reading

Download:

## Direct Answer

Revenue architecture for **vertical SaaS for veterinary clinics** in 2027 — Cornerstone (IDEXX), ezyVet (IDEXX), AVImark (Covetrus), DVMAX (Henry Schein), Hippo Manager, ImproMed (Patterson Veterinary), eVetPractice (Patterson), Shepherd, Provet Cloud, Pulse Veterinary, Vetstoria, PetDesk, Otto, Rhapsody — is structured around **three segments**: Solo/Small Practice (1-2 veterinarians, **$3,600-$11,000 ACV**), Group Practice / Specialty Hospital (3-15 doctors, **$32,000-$220,000 ACV**), and Corporate Group / Roll-up (16-1,800+ locations, **$480,000-$22M ACV**). The dominant motion is **inside-AE with distributor-channel co-sell for Solo, field-AE plus solutions consultant for Group/Specialty, and dedicated enterprise team plus distribution-channel partnerships with IDEXX, Covetrus, Patterson Veterinary, and MWI Animal Health (AmerisourceBergen) for Corporate Group**. **Pipeline coverage runs 3.4x for Solo and 4.8x for Corporate** because vet practice management software incumbency averages **14-21 years per practice** (AVMA 2026 Veterinary Practice Technology Survey). NRR sits at **108-114% for Group** and **122-134% for Corporate** because expansion comes from **doctor count, location count, ancillary modules** (online booking, two-way SMS, payments, lab integration, telemedicine, pet-owner mobile app, AI charting, AI radiograph review). Comp structure pays **50/50 OTE Solo/Group, 45/55 Corporate** with **lab-integration revenue-share and payment processing residuals**. The CRO failure mode unique to vet SaaS: not building **diagnostic-lab co-sell economics with IDEXX, Antech (Mars Petcare via Heska), and Zoetis Reference Labs**, because **lab integration is the highest-leverage GTM moat** in veterinary vertical SaaS — clinics rarely switch PIMS once lab connectivity is established. IDEXX owns Cornerstone and ezyVet specifically because of this dynamic (IDEXX 2026 10-K). Corporate Group acquirers — **Mars Veterinary Health (Banfield, BluePearl, VCA, AniCura), National Veterinary Associates (NVA), VetCor, Pathway Vet Alliance, Compassion-First Pet Hospitals, PetVet Care Centers** — drive **70-80% of new logo growth at the Corporate tier**. Forecast methodology weights **65% expansion / 35% new logo** above 4,000 practices.

## 1. Segment design and ACV bands

### 1.1 Solo / Small Practice (1-2 vets)

**ACV band: $3,600-$11,000**. Module mix: PIMS core (scheduling, medical records, billing) + integrated lab + basic payment processing + sometimes online booking. Sales cycle: **30-72 days**. Decision-maker: vet-owner + Practice Manager. **Win rate: 22-28%**. **Shepherd, Provet Cloud, ezyVet, Hippo Manager, Pulse Veterinary** target this segment as cloud-native alternatives to legacy on-prem Cornerstone and AVImark.

### 1.2 Group Practice / Specialty Hospital (3-15 doctors)

**ACV band: $32,000-$220,000**. Module mix: enterprise PIMS + multi-location reporting + integrated diagnostic lab + radiology PACS + telemedicine + payment processing + pet-owner mobile app + AI radiograph review. Sales cycle: **3-7 months**. Stakeholders: Practice Owner + Hospital Director + Medical Director + IT Lead. **Win rate: 18-24%**. **Cornerstone, ezyVet, Provet Cloud, AVImark Enterprise** dominate.

### 1.3 Corporate Group / Roll-up (16-1,800+ locations)

**ACV band: $480,000-$22M+**. Module mix: full cloud-native enterprise PIMS + multi-state consolidation + acquisition-onboarding workflows + custom data warehouse + corporate-wide medical-protocol enforcement + integrated finance + corporate-tier diagnostic lab contracts. Sales cycle: **9-22 months**. Stakeholders: CEO, CFO, CMO (Chief Medical Officer), CIO, COO, regional VPs, Director of Operations, frequently a PE sponsor. **Win rate: 12-17%**. **Mars Veterinary Health (Banfield + BluePearl + VCA + AniCura, ~3,200 hospitals globally), NVA, VetCor, Pathway, Compassion-First, PetVet, AmeriVet** are the named accounts.

## 2. Pipeline math and conversion benchmarks

### 2.1 Coverage ratios by segment

| Segment | Coverage target | Stage 2 to Close | Win rate | Cycle days |
|---|---|---|---|---|
| Solo | **3.4x** | 22% | 22-28% | 30-72 |
| Group/Specialty | **4.2x** | 16% | 18-24% | 90-220 |
| Corporate | **4.8x** | 11% | 12-17% | 270-660 |

### 2.2 The diagnostic lab moat

Per IDEXX 2026 10-K: **veterinary clinics that run diagnostic lab work in-house (chemistry, hematology, urinalysis) using IDEXX analyzers retain their PIMS for 19+ years on average**. Practices without integrated lab connectivity have **PIMS tenure averaging 11 years**. IDEXX owns Cornerstone and ezyVet specifically to deepen this moat — the **PIMS-lab integration economic flywheel** is the most important strategic asset in the entire veterinary vertical SaaS market.

### 2.3 The Corporate Group acquisition pipeline

Mars Veterinary Health alone acquires **180-340 hospitals per year globally** through Banfield, BluePearl, VCA, and AniCura. NVA, VetCor, Pathway, and PetVet collectively acquire another **400-600 hospitals per year**. **70-80% of new logo growth at the Corporate tier comes from these PIMS-conversion-during-acquisition events** — when a Corporate group acquires an independent practice, they migrate it onto their standardized PIMS within 90 days. The vet vertical SaaS company that has won the **Mars enterprise contract or the NVA enterprise contract** captures that acquisition pipeline automatically.

```mermaid
graph TD
  A[Corporate Group Acquires Independent Practice] --> B[Standard 90-Day PIMS Migration Window]
  B --> C{Which PIMS does Corporate Group standardize on?}
  C -->|Cornerstone IDEXX| D[Cornerstone gains practice + lab attach]
  C -->|ezyVet IDEXX| E[ezyVet gains practice + lab attach]
  C -->|Provet Cloud| F[Provet gains practice]
  C -->|Other| G[Other gains practice]
  D --> H[IDEXX revenue compound: PIMS + lab + analyzers]
  E --> H
```

## 3. Comp structure and OTE bands

### 3.1 Solo Inside-AE

**OTE: $125k-$165k** (50/50). Quota: **$680k-$980k new ARR + $4.2M-$7.2M payment volume**. Accelerator: **1.6x on lab integration + payment dual-attach within 90 days**.

### 3.2 Group / Specialty AE

**OTE: $195k-$265k** (50/50). Quota: **$1.6M-$2.4M new ARR + $14M-$22M payment volume**. **Trailing residual: 6-10 bps payment processing + 12% lab integration revenue share for 24 months post-go-live**.

### 3.3 Corporate Group AE

**OTE: $320k-$485k** (45/55). Quota: **$3.6M-$5.8M new ARR**. Multi-year vesting (60/25/15). **Draw $60k-$100k** for first 12 months because cycle is 9-22 months.

### 3.4 Distributor/Channel Manager

**OTE: $185k-$260k** (60/40). Required for IDEXX, Covetrus, Patterson Veterinary, MWI Animal Health partnerships. Variable on **distributor-rep referral pipeline + co-marketing + distributor-influenced ACV**.

### 3.5 Corporate Acquisition Onboarding overlay

**OTE: $135k-$180k** (75/25). Variable on **per-acquired-practice on-time migration within 90 days** of corporate acquisition close. This role typically pays **$10k-$24k per successfully migrated practice** above baseline.

### 3.6 CSM

**OTE: $98k-$132k** (70/30). Quota: **$320k-$460k expansion ARR + 96% logo retention + 92% gross retention + 94% lab integration retention**.

## 4. Org design and reporting structure

### 4.1 RevOps reporting line

**RevOps reports to CRO**. RevOps owns: territory design, comp plan, deal desk, **lab-integration revenue-share reconciliation engine** (this is a $30M-$200M revenue item that requires GTM-native ownership), distributor-channel attribution, payment residual reconciliation, corporate-acquisition-onboarding pipeline.

### 4.2 Org chart

```mermaid
graph LR
  CRO[CRO] --> Sales[VP Sales]
  CRO --> CS[VP Customer Success]
  CRO --> Channel[VP Distributor Channel]
  CRO --> Corp[VP Corporate Enterprise]
  CRO --> RevOps[VP RevOps]
  Sales --> SoloAE[Solo Inside AE]
  Sales --> GroupAE[Group Field AE]
  Sales --> SC[Solutions Consultants]
  CS --> CSM[CSM]
  CS --> AcqOnboard[Corporate Acquisition Onboarding]
  Channel --> IdexxChan[IDEXX Channel]
  Channel --> CovetChan[Covetrus Channel]
  Channel --> PattChan[Patterson Vet Channel]
  Channel --> MWIChan[MWI Animal Health Channel]
  Corp --> CorpFAE[Corporate Field AE]
  Corp --> CorpSC[Corporate Solutions Consultants]
  RevOps --> LabRecon[Lab Revenue Share Recon]
  RevOps --> DealDesk[Deal Desk]
  RevOps --> CorpAcqPipe[Corporate Acquisition Pipeline]
```

## 5. Forecast methodology and operating cadence

### 5.1 Weighted-stage forecast by motion

- **Solo**: monthly commit with weekly slip.
- **Group/Specialty**: monthly commit with monthly stakeholder review.
- **Corporate**: quarterly commit with monthly named-account stakeholder review + monthly Corporate Group acquisition pipeline review.

### 5.2 Install-base expansion weighting

Above 4,000 practices, **65% expansion / 35% new logo**. Below 4,000, **60/40 new logo / expansion**. EzyVet operates at ~9,500 practices globally; Cornerstone at ~14,000; ImproMed at ~6,000.

### 5.3 2027 operating cadence

Weekly: pipeline council, distributor-channel pipeline review. Monthly: lab-integration revenue review, payment-attach review, **Corporate acquisition pipeline review** (Mars + NVA + VetCor + Pathway + PetVet), CSM expansion forecast. Quarterly: comp calibration, distributor partner business review, Board NRR + gross retention deep-dive.

## 6. Renewal, expansion, and pricing architecture

### 6.1 NRR targets

- **Solo**: 102-108%
- **Group/Specialty**: 108-114%
- **Corporate**: 122-134%

Best-in-class composite NRR (ezyVet 2026 disclosed via IDEXX): **119%**. Provet Cloud 2026: **114%**. Cornerstone 2026: **108%** (slower because of legacy module-attach maturity).

### 6.2 Pricing and packaging in 2027

- PIMS core: **$280-$780/month/practice**
- Online booking + two-way SMS: **$220-$480/month/practice**
- Payment processing: **80-110 bps + $0.14-$0.24 per transaction**
- AI charting / AI radiograph (Antech, SignalPET, Zoetis Vetscan Imagyst): **$340-$1,400/month/practice**
- Telemedicine / virtual care: **$180-$420/month/practice**
- Enterprise Corporate tier (per location): **$780-$2,800/month/practice**
- Implementation fee: **$4k-$60k per practice**

### 6.3 Expansion comp triggers

- **Doctor add**: 30% expansion credit
- **Location add** (Corporate acquisition or new build): full new-logo credit
- **Lab integration activation + 60 days live**: 100% expansion credit + 1.4x accelerator (this is the highest-leverage trigger in vet SaaS)
- **AI tier upgrade**: 80% expansion credit
- **Telemedicine module + 60 days live**: 60% expansion credit

## 7. Failure modes specific to revenue STRUCTURE

### 7.1 No diagnostic-lab co-sell economics

The **single largest strategic failure** in vet vertical SaaS that is not owned by IDEXX, Antech, or Zoetis. Without explicit lab-integration revenue share, the PIMS vendor loses the **19-year retention moat** that lab integration creates. Provet Cloud and ezyVet both built lab integration partnerships with multiple lab providers; standalone PIMS vendors that don't will see **20+ percentage points of NRR drift** over 24 months.

### 7.2 No Corporate Group acquisition pipeline tracking

Mars Veterinary Health alone acquires **180-340 hospitals/year**. If RevOps does not track **which Corporate Group has acquired which practice this month** and **route the 90-day migration to the Corporate Acquisition Onboarding overlay**, the vendor loses **40-60 acquired-practice migrations per year per Corporate contract**.

### 7.3 No distributor channel comp

Roughly **42% of Solo and Small vet practice software purchases originate through a distributor relationship** (Patterson Veterinary, Covetrus, MWI, Henry Schein). Without channel-rep comp, the distributor reps stop referring. IDEXX's internal model: **12-15% of first-year ACV to the IDEXX rep on distributor-originated PIMS deals**.

### 7.4 Solo and Corporate on the same comp plan

Solo cycles 30-72 days. Corporate cycles 270-660 days. **Separate plans, separate ramp curves, separate draw structures**.

## FAQ

**Q: What is the right NRR target for vet vertical SaaS at the Group/Specialty segment?**
A: **108-114% blended**, with **122-134% for Corporate** and **102-108% for Solo**. EzyVet 2026 disclosed 119% composite.

**Q: How important is lab integration as a retention moat?**
A: It is **the single most important retention asset** in vet vertical SaaS. Practices with integrated diagnostic lab connectivity retain their PIMS **19+ years**. Practices without retain only **11 years** (IDEXX 2026 10-K). The lab-integration revenue share also drives **15-22 percentage points of NRR** for the PIMS vendor that has it.

**Q: What share of Corporate Group new logo wins come from acquired-practice migrations?**
A: **70-80%**. Mars Veterinary Health acquires 180-340 hospitals/year globally. NVA + VetCor + Pathway + PetVet collectively acquire 400-600/year. The vendor with the Corporate enterprise contract captures the migration pipeline automatically.

**Q: How should comp work for distributor partnerships with IDEXX, Covetrus, Patterson Vet, MWI?**
A: **Dedicated Distributor Channel Manager (OTE $185k-$260k, 60/40)** with variable on distributor-rep referral pipeline + co-marketing + distributor-influenced ACV. IDEXX's internal model pays **12-15% of first-year ACV** to the rep on distributor-originated PIMS deals.

**Q: What is the right ramp for a Corporate vet AE?**
A: **9-month ramp with $60k-$100k draw**, multi-year vesting **60% Year 1 / 25% Year 2 / 15% Year 3** because cycles are 270-660 days and implementations 3-9 months. Without draw + multi-year vesting, attrition runs **34-42% before first commission event**.

**Q: Where should the Corporate Acquisition Onboarding overlay sit organizationally?**
A: **Under VP Customer Success**, with variable comp on **per-acquired-practice on-time migration within 90 days** of Corporate acquisition close. Typical comp: **$10k-$24k per successfully migrated practice above baseline**.

**Q: What forecast cadence works for Corporate Group accounts?**
A: **Quarterly commit + monthly stakeholder-map review + monthly Corporate Group acquisition pipeline review.** The acquisition pipeline review is what most vet vertical SaaS RevOps teams miss — it should be a standalone forum on the operating cadence.

## Bottom Line

Veterinary vertical SaaS in 2027 is **lab-integration-defended at the PIMS layer, distributor-channel-driven at the SMB tier, and acquisition-pipeline-driven at the Corporate tier**. **Three segments — Solo / Group / Corporate — on separate comp plans with separate ramp curves.** AE comp on **SaaS ARR + payment residuals + lab integration revenue share + Corporate acquisition onboarding overlay**. A **Distributor Channel team** is mandatory at $20M+ ARR. A **Corporate Acquisition Onboarding overlay** is mandatory at the Corporate tier. **RevOps reporting to CRO**. NRR targets **108-134%** by segment. Pipeline coverage **3.4x Solo / 4.2x Group / 4.8x Corporate**. The CRO who skips lab-integration revenue-share economics will see **20+ percentage points of NRR drift** over 24 months as Corporate Group acquirers consolidate onto IDEXX-owned platforms (Cornerstone, ezyVet) by default.

## Sources

- IDEXX Laboratories 2026 10-K and 2027 Q1 earnings
- Covetrus 2026 financial disclosures (post-Clayton Dubilier & Rice acquisition update)
- Patterson Companies 2026 10-K (Patterson Veterinary segment)
- AmerisourceBergen / MWI Animal Health 2026 segment reporting
- Mars Veterinary Health 2027 corporate overview (Banfield, BluePearl, VCA, AniCura, AniCura Group disclosures)
- AVMA (American Veterinary Medical Association) 2026 Veterinary Practice Technology Survey
- Bessemer Venture Partners — Vertical SaaS Benchmarks 2027
- Forrester — Veterinary Practice Management Wave 2026
- Provet Cloud 2026 funding announcement and analyst commentary
- Veterinary Practice News — PIMS Market Share Report 2027
- Vetsource / IDEXX combined market research 2026
- Pet Industry Joint Advisory Council 2027 Veterinary Tech Report

Was this helpful?

⌬ Apply this in PULSE

Industry KPIs · SaaSThe 9 sales KPIs that matter for SaaS

Related in the library